Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular

Ru Feng Xie1, Ping Hu2, Zhi Cheng Wang3

  • 1Shanghai Blood Center, Shanghai, China.

Transfusion
|January 8, 2015
PubMed
Abstract

Insights

Platelet microparticles (PMPs) concentrate soluble CD40 ligand (sCD40L), exacerbating polymorphonuclear leukocyte (PMN)-mediated damage to human pulmonary microvascular endothelial cells (HMVECs) and potentially contributing to transfusion-related acute lung injury.

Area of Science:

  • Transfusion Medicine
  • Immunology
  • Cell Biology

Background:

  • Stored platelets accumulate microparticles and biologic response modifiers (BRMs).
  • BRMs can induce inflammatory reactions in transfusion recipients.
  • Mechanisms of BRM effects remain unclear.

Purpose of the Study:

  • Investigate platelet microparticle (PMP) effects on polymorphonuclear leukocyte (PMN)-mediated human pulmonary microvascular endothelial cell (HMVEC) damage.
  • Determine the role of soluble CD40 ligand (sCD40L) in this process.

Main Methods:

  • Isolated PMPs from apheresis platelet concentrates.
  • Utilized a two-insult in vitro model of HMVEC damage.
  • Measured PMN priming activity, hydrogen peroxide production, and expression of ICAM-1 and CD11b.

Main Results:

  • PMP and sCD40L concentration influenced HMVEC damage and PMN respiratory burst.
  • Apocynin-treated PMNs significantly reduced PMP-induced HMVEC damage.
  • PMP priming increased CD11b expression on PMNs, and ICAM-1 blockade reduced HMVEC damage.

Conclusions:

  • PMPs concentrate CD40L, promoting PMN-mediated HMVEC damage.
  • This mechanism may contribute to transfusion-related acute lung injury (TRALI).